MAS
Masco Corporation
MAS has the edge over RKLB overall, supported by lower modeled downside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
MAS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
MAS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
MAS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $59.97 | -29% |
| Fair | 17x | $79.10 | -6.4% |
| Current | 18x | $84.48 | — |
| Forward | 18x | $84.48 | — |
| Expensive | 21x | $97.54 | +15% |
Historical ranges are pointers, not guarantees.
MAS's PE is in its fair range at 18.3x. On analysts' estimates for next year's earnings, today's price would be 18.5x.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
MAS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect MAS's earnings to grow and its profitability to improve, with its revenue holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over MAS on the outlook, with more favorable revenue expectations.
MAS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | -1.1% |
| Q3 2026 | $4.63 | +19% |
| Q2 2026 | $4.36 | +16% |
| Q1 2026 | $4.04 | +10% |
| Q4 2025 | $3.86 | +2.7% |
| Q3 2025 | $3.90 | +3.4% |
| Q2 2025 | $3.77 | -8% |
| Q1 2025 | $3.66 | -11% |
| Q4 2024 | $3.76 | -6.5% |
MAS has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
MAS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +2.6% |
| Q2 2026 | $2B | -2.9% |
| Q1 2026 | $1.9B | +6.5% |
| Q4 2025 | $1.8B | -1.9% |
| Q3 2025 | $1.9B | -3.3% |
| Q2 2025 | $2.1B | -1.9% |
| Q1 2025 | $1.8B | -6.5% |
| Q4 2024 | $1.8B | -2.9% |
MAS's revenue fell from its 2022 peak and has held roughly level since: $2B last quarter, up 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +1.4 points |
| Q2 2026 | 24% | +3.5 points |
| Q1 2026 | 16% | +0.6 points |
| Q4 2025 | 14% | -2.1 points |
| Q3 2025 | 16% | -2.2 points |
| Q2 2025 | 20% | +1.1 points |
| Q1 2025 | 16% | -0.6 points |
| Q4 2024 | 16% | +2.7 points |
MAS has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over MAS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
MAS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $332M | -20% |
| Q2 2026 | $453M | +68% |
| Q1 2026 | -$113M | +$77M |
| Q4 2025 | $371M | +5.7% |
| Q3 2025 | $415M | +9.8% |
| Q2 2025 | $270M | -11% |
| Q1 2025 | -$190M | -$65M |
| Q4 2024 | $351M | -17% |
MAS has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
MAS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.5x | Healthy |
MAS's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MAS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.2 | Neutral |
| Stochastic | 80.3 | Overbought |
MAS's weekly RSI is 66 (neutral) and its Stochastic is 80 (overbought).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
MAS PE vs Industrials Sector
| Metric | MAS | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 24% below |
| PE % | 59 | 58 | 1 pt above |
MAS is trading at 18x earnings, a 24% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
MAS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $75.3 | 12% above |
| 20 week MA | $75.0 | 13% above |
| 50 week MA | $70.8 | 19% above |
| 100 week MA | $69.8 | 21% above |
| 200 week MA | $67.4 | 25% above |
MAS has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
MAS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.1 | $56.8 | +18% |
| 2021 | $56.8 | $68.0 | +20% |
| 2022 | $68.0 | $47.1 | -31% |
| 2023 | $47.1 | $67.0 | +42% |
| 2024 | $67.0 | $73.2 | +9.3% |
| 2025 | $73.2 | $64.7 | -12% |
| 2026 YTD | $64.7 | $84.5 | +30% |
MAS has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.